← Back to Clinical Trials
Recruiting NCT05500833

NCT05500833 Multidimensional Characterization of Dyspnea in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05500833
Status Recruiting
Phase —
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Dyspnea and Respiratory Insufficiency in Children
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2023-01-26
Primary Completion 2028-02-26

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 17 Years
Study Type OBSERVATIONAL
Interventions
Multidimentional observation scale (MDP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2023-01-26 with a primary completion date of 2028-02-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

There is no specific tool existing to describe dyspnea in children in a multidimensional way. It has been shown in adult studies that multidimensional dyspnea evaluation scales are well correlated to quality of life and respiratory function impairments. The investigators hypothesis is that using multidimensional dyspnea evaluation scales could allow for a more systematic and precise evaluation of this symptom in children, thus improving management and follow-up of patients presenting with acute (asthma attack, infectious diseases) and chronic (cystic fibrosis, primary ciliary diskynesia, neuromuscular diseases) respiratory insufficiency.

Eligibility Criteria

Inclusion Criteria: * Children aged between 6-17 years old at inclusion * Experiencing respiratory complaints at inclusion * Social security number * Children whom parents or legal representatives are present or reachable via phone call at inclusion * Non-opposition of parents or legal representatives to participate in the study * Children who are followed at or hospitalized in Trousseau hospital's pediatric pulmonology department for: asthma attack, acute respiratory insufficiency, acute exacerbation of a chronic respiratory disease, chronic respiratory insufficiency. * For the study of acute dyspnea: patients hospitalized for acute respiratory disease since less than 72h. * For the study of chronic dyspnea: children presenting with chronic respiratory disease. Exclusion Criteria: * Cognitive disorders making it impossible to understand self-assessment scales * Refusal of the child to participate in the research For the assessment of chronic dyspnea: * Children followed for a chronic respiratory pathology having presented an episode of acute respiratory decompensation in the 6 weeks preceding inclusion.

Contact & Investigator

Central Contact

Jessica TAYTARD, MD, PhD

✉ jessica.taytard@aphp.fr

📞 +33677855889

Frequently Asked Questions

Who can join the NCT05500833 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Dyspnea and Respiratory Insufficiency in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05500833 currently recruiting?

Yes, NCT05500833 is actively recruiting participants. Contact the research team at jessica.taytard@aphp.fr for enrollment information.

Where is the NCT05500833 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT05500833 clinical trial?

NCT05500833 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology